Nanodigmbio-NGS Lung cancer panel

Product catalog summary

Introduction
LungCancer Panel v1.0 is designed for lung cancer research, focusing on 24 genes, including full coding regions from 19 genes and non-exonic regions with frequent fusion occurrences.

Application
This panel is used for analyzing gene mutations related to lung cancer, such as base substitution, fragment insertion/deletion, gene rearrangement, and gene amplification.

Specification
The panel is available in two scales: 16 reactions (Catalog# 1001922) and 96 reactions (Catalog# 1001921), both requiring 4 μL per reaction and stored at -25 ~ -15℃.

Instruction
The panel is optimized with NadPrep Hybrid Capture Reagents for targeted capture applications. Specific instructions are provided for Illumina® and MGI platforms. Each hybridization reaction requires 13 μL of hybridization master mix and 4 μL of the panel.

Recommendation
Various NadPrep products are recommended for use with the panel, including NanoBlockers and Hybrid Capture Reagents, all stored at -25 ~ -15℃.

Attention
Reagents should be handled in a clean bench to avoid contamination, and tubes should be vortexed and centrifuged before opening. Avoid repeated freezing and thawing.

Statement
The panel is for research use only and not for diagnostic procedures. Nanodigmbio Pte. Ltd. reserves all rights.

Catalog excerpts

We provide molecular reagents to serve precision medicine. LungCancer Panel v1.0 is specifically designed for lung cancer research. This panel involves 24 genes, including full coding regions from 19 genes and non-exonic regions with frequent fusion occurrence in lung cancer. This panel is used for lung cancer related gene mutations analysis, including base substitution, fragment insertion/deletion, gene rearrangement and gene amplification. Item Catalog# Scale Usage Storage Note: From June 1st, 2021, LungCancer Research Panel v1.0 has been renamed LungCancer Panel v1.0, and the catalog remains unchanged. • This panel has been optimized with NadPrep Hybrid Capture Reagents for targeted capture applications. Please refer to the user manual from Nanodigmbio (www.nanodigmbio.com). For Illumina® platforms, please refer to the Hybridization Capture of DNA Libraries (for Illumina®) _v2.3. For MGI platforms, please refer to the Hybridization Capture of DNA Libraries (for MGI)_v1.4. • The hybrid capture reagents need to be thoroughly vortex and centrifuge prior to use. Each hybridization reaction consists of 13 |iL of hybridization master mix and 4 |iL of LungCancer Panel v1.0. Note: Each hybridization master mix consists of 8.5 |iL of Hyb #1, 2.7 |iL of Hyb #2 and 1.8 |iL of Nuclease Free Water. • The LungCancer Panel v1.0 can either be used independently or as spike-in panel. Please contact us ([email protected]) for professional and specific recommendations. • Please refer to the panel information (LungCancer _Panel_v1.0_Covered_hg19.bed) from Nanodigmbio (www.nanodigmbio.com) for targeted capture analysis. Service: [email protected] | Web: www.nanodigmbio.com

Open the catalog to page 1

We provide molecular reagents to serve precision medicine. Catalog# Storage NadPrep Hybrid Capture Reagents NadPrep NanoBlockers (for Illumina®), 96 rxn NadPrep NanoBlockers (for MGI, SI), 96 rxn NadPrep NanoBlockers (for MGI, DI), 96 rxn NadPrep Hybrid Capture Reagents, 16 rxn NadPrep Hybrid Capture Reagents, 96 rxn NadPrep Amplification Primer Mix (for Illumina®), 96 rxn NadPrep M-Amplification Primer Mix (for MGI, SI), 96 rxn NadPrep M-Amplification Primer Mix (for MGI, DI), 96 rxn Attention • Perform all reagent handlings in the clean bench to avoid contamination. • Thoroughly vortex and...

Open the catalog to page 2

All Nanodigmbio catalogs and technical brochures

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.

Brand list